Tenon Medical, Inc. TNON

Company Overview

Tenon Medical, Inc. is a U.S.-based medical technology company focused on the development and commercialization of surgical solutions for sacroiliac (SI) joint disorders. The company operates within the orthopedic and spine device industry, with a primary emphasis on minimally invasive surgical implants used to stabilize and fuse the SI joint in patients suffering from chronic lower back pain associated with SI joint dysfunction. Its principal revenue driver is the commercialization of the Catamaran SI Joint Fusion System, a proprietary implant platform designed to provide structural fixation and long-term stabilization of the SI joint.

The company primarily serves spine surgeons, orthopedic specialists, ambulatory surgery centers, and hospitals in the United States. Tenon Medical positions itself within the growing market for minimally invasive spine and pelvic procedures by emphasizing implant design intended to maximize bone preservation and fixation strength. The company was founded in 2012 and later became publicly traded on the Nasdaq under the ticker TNON following its initial public offering in 2022. Since inception, the company has focused on expanding clinical adoption of its SI joint fusion technology and building surgeon education programs around its procedural platform.